RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives $3.00 Average Target Price from Brokerages
Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) have received a consensus rating of “Hold” from the six analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and one […]
Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) have received a consensus rating of “Hold” from the six analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and one […]
